Logo image of SLNH

SOLUNA HOLDINGS INC (SLNH) Stock Fundamental Analysis

NASDAQ:SLNH - Nasdaq - US5835433013 - Common Stock - Currency: USD

1.45  0 (0%)

After market: 1.45 0 (0%)

Fundamental Rating

2

SLNH gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 284 industry peers in the Software industry. Both the profitability and financial health of SLNH have multiple concerns. While showing a medium growth rate, SLNH is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year SLNH has reported negative net income.
In the past year SLNH has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: SLNH reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: SLNH reported negative operating cash flow in multiple years.
SLNH Yearly Net Income VS EBIT VS OCF VS FCFSLNH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M -60M -80M

1.2 Ratios

The Return On Assets of SLNH (-30.84%) is worse than 78.99% of its industry peers.
SLNH has a Return On Equity of -143.80%. This is amonst the worse of the industry: SLNH underperforms 82.25% of its industry peers.
Industry RankSector Rank
ROA -30.84%
ROE -143.8%
ROIC N/A
ROA(3y)-50.87%
ROA(5y)-24.88%
ROE(3y)-117.17%
ROE(5y)-62.01%
ROIC(3y)N/A
ROIC(5y)N/A
SLNH Yearly ROA, ROE, ROICSLNH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150 -200

1.3 Margins

With a Gross Margin value of 35.03%, SLNH is not doing good in the industry: 80.43% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of SLNH has declined.
SLNH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 35.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.75%
GM growth 5Y-18.98%
SLNH Yearly Profit, Operating, Gross MarginsSLNH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 -200

More info and screens

1

2. Health

2.1 Basic Checks

SLNH does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SLNH has more shares outstanding
Compared to 5 years ago, SLNH has more shares outstanding
The debt/assets ratio for SLNH has been reduced compared to a year ago.
SLNH Yearly Shares OutstandingSLNH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M 2M 2.5M
SLNH Yearly Total Debt VS Total AssetsSLNH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

SLNH has an Altman-Z score of -3.99. This is a bad value and indicates that SLNH is not financially healthy and even has some risk of bankruptcy.
SLNH's Altman-Z score of -3.99 is on the low side compared to the rest of the industry. SLNH is outperformed by 82.97% of its industry peers.
SLNH has a Debt/Equity ratio of 0.55. This is a neutral value indicating SLNH is somewhat dependend on debt financing.
SLNH's Debt to Equity ratio of 0.55 is on the low side compared to the rest of the industry. SLNH is outperformed by 69.20% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF N/A
Altman-Z -3.99
ROIC/WACCN/A
WACC10.44%
SLNH Yearly LT Debt VS Equity VS FCFSLNH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M

2.3 Liquidity

SLNH has a Current Ratio of 0.59. This is a bad value and indicates that SLNH is not financially healthy enough and could expect problems in meeting its short term obligations.
SLNH's Current ratio of 0.59 is on the low side compared to the rest of the industry. SLNH is outperformed by 90.58% of its industry peers.
SLNH has a Quick Ratio of 0.59. This is a bad value and indicates that SLNH is not financially healthy enough and could expect problems in meeting its short term obligations.
SLNH has a worse Quick ratio (0.59) than 90.22% of its industry peers.
Industry RankSector Rank
Current Ratio 0.59
Quick Ratio 0.59
SLNH Yearly Current Assets VS Current LiabilitesSLNH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 85.11% over the past year.
Looking at the last year, SLNH shows a very strong growth in Revenue. The Revenue has grown by 163.50%.
The Revenue has been growing by 21.19% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)85.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.84%
Revenue 1Y (TTM)163.5%
Revenue growth 3Y227.45%
Revenue growth 5Y21.19%
Sales Q2Q%29.74%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SLNH Yearly Revenue VS EstimatesSLNH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
SLNH Yearly EPS VS EstimatesSLNH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

SLNH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SLNH Price Earnings VS Forward Price EarningsSLNH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SLNH indicates a somewhat cheap valuation: SLNH is cheaper than 74.64% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 31.65
SLNH Per share dataSLNH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4 -6 -8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SLNH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SOLUNA HOLDINGS INC

NASDAQ:SLNH (2/21/2025, 8:00:02 PM)

After market: 1.45 0 (0%)

1.45

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-12 2024-08-12/amc
Earnings (Next)N/A N/A
Inst Owners10.45%
Inst Owner Change-79.77%
Ins Owners19.93%
Ins Owner Change32.04%
Market Cap24.37M
Analysts0
Price TargetN/A
Short Float %6.17%
Short Ratio1.59
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.61
P/FCF N/A
P/OCF N/A
P/B 1.17
P/tB 27.42
EV/EBITDA 31.65
EPS(TTM)-8.89
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.36
FCFYN/A
OCF(TTM)-0.12
OCFYN/A
SpS2.37
BVpS1.24
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -30.84%
ROE -143.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 35.03%
FCFM N/A
ROA(3y)-50.87%
ROA(5y)-24.88%
ROE(3y)-117.17%
ROE(5y)-62.01%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.75%
GM growth 5Y-18.98%
F-Score5
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF N/A
Debt/EBITDA 9.5
Cap/Depr 26.22%
Cap/Sales 10.28%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.59
Quick Ratio 0.59
Altman-Z -3.99
F-Score5
WACC10.44%
ROIC/WACCN/A
Cap/Depr(3y)533.81%
Cap/Depr(5y)540.56%
Cap/Sales(3y)204.65%
Cap/Sales(5y)150.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)85.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.84%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)163.5%
Revenue growth 3Y227.45%
Revenue growth 5Y21.19%
Sales Q2Q%29.74%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y43.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y93.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-155.84%
OCF growth 3YN/A
OCF growth 5YN/A